ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Missouri » Ophthalmology

Top Ophthalmology Prescribers in Missouri

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
JOHN GALANIS

Ophthalmology

5,164

$296K

1008
945 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

60%
prescriptions for brand name drugs

Avg: 62%

$57
Average prescription price

Avg: $76

JOHANN OHLY MD

Ophthalmology

5,027

$294K

692
626 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

52%
prescriptions for brand name drugs

Avg: 62%

$59
Average prescription price

Avg: $76

JOHN FITZ M.D.

Ophthalmology

4,513

$376K

752
614 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

76%
prescriptions for brand name drugs

Avg: 62%

$83
Average prescription price

Avg: $76

ROHIT KRISHNA MD

Ophthalmology

4,225

$357K

735
670 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

67%
prescriptions for brand name drugs

Avg: 62%

$85
Average prescription price

Avg: $76

KENNETH NEU M.D.

Ophthalmology

4,205

$182K

746
670 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

47%
prescriptions for brand name drugs

Avg: 62%

$43
Average prescription price

Avg: $76

GREGG BERDY M.D.

Ophthalmology

4,091

$511K

620
571 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

84%
prescriptions for brand name drugs

Avg: 62%

$125
Average prescription price

Avg: $76

NAVIN TEKWANI MD

Ophthalmology

3,951

$367K

880
809 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

77%
prescriptions for brand name drugs

Avg: 62%

$93
Average prescription price

Avg: $76

DERRALL PARKER M.D.

Ophthalmology

3,776

$231K

646
568 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

4%
patients receiving schedule three controlled substances

Avg: 1%

7%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

56%
prescriptions for brand name drugs

Avg: 62%

$61
Average prescription price

Avg: $76

ROGER BONHAM M.D.

Ophthalmology

3,731

$238K

612
583 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

66%
prescriptions for brand name drugs

Avg: 62%

$64
Average prescription price

Avg: $76

NAVIN AMIN M.D.

Ophthalmology

3,587

$223K

531
481 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

62%
prescriptions for brand name drugs

Avg: 62%

$62
Average prescription price

Avg: $76

ROBERT JONES M.D.

Ophthalmology

3,540

$267K

761
631 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

4%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

76%
prescriptions for brand name drugs

Avg: 62%

$75
Average prescription price

Avg: $76

RANJAN MALHOTRA MD

Ophthalmology

3,484

$588K

652
596 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

91%
prescriptions for brand name drugs

Avg: 62%

$169
Average prescription price

Avg: $76

ANTHONY LUBNIEWSKI MD

Ophthalmology

3,318

$327K

465
389 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

62%
prescriptions for brand name drugs

Avg: 62%

$99
Average prescription price

Avg: $76

BRADLEY STUCKENSCHNEIDER M.D.

Ophthalmology

3,230

$189K

781
674 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

70%
prescriptions for brand name drugs

Avg: 62%

$59
Average prescription price

Avg: $76

CARLA SIEGFRIED MD

Ophthalmology

3,213

$273K

441
405 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

63%
prescriptions for brand name drugs

Avg: 62%

$85
Average prescription price

Avg: $76

FRANCIS JANSEN M.D.

Ophthalmology

3,187

$152K

799
687 are 65+

5%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

16%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

51%
prescriptions for brand name drugs

Avg: 62%

$48
Average prescription price

Avg: $76

STEVEN LEE MD

Ophthalmology

3,142

$464K

726
650 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

87%
prescriptions for brand name drugs

Avg: 62%

$148
Average prescription price

Avg: $76

JAMES OVERLEASE M.D.

Ophthalmology

3,026

$146K

462
408 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

52%
prescriptions for brand name drugs

Avg: 62%

$48
Average prescription price

Avg: $76

WILLIAM SCIORTINO M.D.

Ophthalmology

2,932

$203K

643
608 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

60%
prescriptions for brand name drugs

Avg: 62%

$69
Average prescription price

Avg: $76

ANTON BEFFA M.D.

Ophthalmology

2,909

$245K

524
440 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

80%
prescriptions for brand name drugs

Avg: 62%

$84
Average prescription price

Avg: $76

CHARLES SHERROD M.D.

Ophthalmology

2,892

$172K

648
612 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

66%
prescriptions for brand name drugs

Avg: 62%

$59
Average prescription price

Avg: $76

JOHN GOLTSCHMAN MD

Ophthalmology

2,881

$203K

683
648 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

76%
prescriptions for brand name drugs

Avg: 62%

$70
Average prescription price

Avg: $76

KEVIN PIKEY D.O.

Ophthalmology

2,816

$267K

479
437 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

74%
prescriptions for brand name drugs

Avg: 62%

$95
Average prescription price

Avg: $76

DOUGLAS DEHNING MD

Ophthalmology

2,795

$262K

936
870 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

4%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

73%
prescriptions for brand name drugs

Avg: 62%

$94
Average prescription price

Avg: $76

HOWARD SHORT MD, FACS

Ophthalmology

2,697

$260K

684
630 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

82%
prescriptions for brand name drugs

Avg: 62%

$96
Average prescription price

Avg: $76

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank